Profil
John J.
Koleng is the founder of Alphavektor LLC, which was founded in 2008.
Dr. Koleng is also the founder of Axxis Innovations, Inc. Dr. Koleng's current job is Vice President-Product Development & Manufacturing at TFF Pharmaceuticals, Inc. Dr. Koleng is also a founding member at Via Therapeutics LLC and Cloxero Therapeutics, Inc. Dr. Koleng's former jobs include being a VP-Industrial Operations & Founding Member at Formulation Technologies LLC and a founding member at Oticara, Inc. Dr. Koleng completed his undergraduate degree in 1994 and his doctorate degree in 2002 at The University of Texas at Austin.
Postes actifs de John J. Koleng
| Sociétés | Poste | Début |
|---|---|---|
| TFF PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Via Therapeutics LLC | Corporate Officer/Principal | - |
Cloxero Therapeutics, Inc. | Corporate Officer/Principal | - |
Anciens postes connus de John J. Koleng
| Sociétés | Poste | Fin |
|---|---|---|
Formulation Technologies LLC
Formulation Technologies LLC Medical/Nursing ServicesHealth Services Delivers drug product solutions that help clients reduce development costs and accelerate time-to-market | Directeur des opérations | - |
Axxis Innovations, Inc. | Fondateur | - |
Oticara, Inc.
Oticara, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that helps ENT physicians patients with sinus and ear conditions | Corporate Officer/Principal | - |
Alphavektor LLC | Fondateur | - |
Formation de John J. Koleng
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Formulation Technologies LLC
Formulation Technologies LLC Medical/Nursing ServicesHealth Services Delivers drug product solutions that help clients reduce development costs and accelerate time-to-market | Health Services |
TFF Pharmaceuticals, Inc.
TFF Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures inhaled dry powder drugs for the treatment of pulmonary diseases and conditions | Health Technology |
Alphavektor LLC | |
Oticara, Inc.
Oticara, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that helps ENT physicians patients with sinus and ear conditions | Health Technology |
Axxis Innovations, Inc. | |
Via Therapeutics LLC | |
Cloxero Therapeutics, Inc. |
















